
201 - 500 employees
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $250k Seed Round on 2010-12
Healthcare • Biotechnology • Pharmaceuticals
KCAS Bioanalytical & Biomarker Services is a full-service global bioanalytical Contract Research Organization (CRO) that offers comprehensive GLP/GCP compliant development services. Specializing in bioanalytical and biomarker services, KCAS Bio supports drug development with a range of services including immunogenicity testing, large and small molecule bioanalysis, flow cytometry, and sample management. With over 40 years of experience, the company has contributed to the support of over 300 FDA-approved drugs and developed more than 5,000 assays. KCAS Bio operates globally, with locations in the US, EU, and strategic alliances in Australia, and is recognized for its innovative approach to maintaining seamless operations and minimizing drug development delays. The company’s expertise spans multiple therapeutic areas including oncology, metabolic, infectious diseases, and neurological conditions.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 September 15
Director of Business Development selling KCAS Bio’s bioanalytical and biomarker services. Growing Southeast U.S. business through complex technical sales and customer partnerships.
🇺🇸 United States – Remote
💰 $250k Seed Round on 2010-12
⏰ Full Time
🔴 Lead
💰 Business Development (BDR)
👻 Ghost score 10%
🕒 August 19
Director of Key Accounts expanding strategic client relationships for KCAS Bio, a contract research organization advancing human and animal health. Driving bioanalytical services growth, bookings, and revenue across key accounts.